NCT04080596View on ClinicalTrials.gov

DDI Study to Investigate the Impact of Itraconazole on the Pharmacokinetics of Dorzagliatin

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 13, 2017

Primary Completion Date

December 5, 2017

Study Completion Date

December 5, 2017

Conditions
Drug Interaction
Interventions
DRUG

Dorzagliatin

GKA for T2DM currently under clinical development

Trial Locations (1)

130021

The 2nd Hospital of Jilin University, Changchun

Sponsors
All Listed Sponsors
lead

Hua Medicine Limited

INDUSTRY

NCT04080596 - DDI Study to Investigate the Impact of Itraconazole on the Pharmacokinetics of Dorzagliatin | Biotech Hunter | Biotech Hunter